CORRESP Filing
ENvue Medical, Inc.
Date: May 14, 2025 · CIK: 0001326706 · Accession: 0001641172-25-010210
AI Filing Summary & Sentiment
File numbers found in text: 333-284973
Show Raw Text
CORRESP 1 filename1.htm NanoVibronix, Inc. 969 Pruitt Place Tyler TX 75703 May 14, 2025 VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission Washington, D.C. 20549 Attention: Jane Park Re: NanoVibronix, Inc. Registration Statement on Form S-1 Originally filed on February 14, 2025, as amended on April 22, 2025, April 29, 2025, May 12, 2025, and May 14, 2025 File No. 333-284973 (as amended, the "Registration Statement") Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the " Commission ") under the Securities Act of 1933, as amended, NanoVibronix, Inc. (the " Company "), hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 4:00 p.m., Eastern Time, on May 14, 2025, or as soon thereafter as practicable. Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Alla Digilova, Esq. at (212) 659-4993. Very truly yours, Nanovibronix, Inc. By: /s/ Stephen Brown Stephen Brown Chief Financial Officer cc: Alla Digilova, Esq., Haynes and Boone, LLP